カテゴリー： Market Monitor Global, 世界, 医療/バイオ

副腎皮質ステロイド点眼薬の世界市場見通し2023年-2029年

◆英語タイトル：Corticosteroid Eyedrops Market, Global Outlook and Forecast 2023-2029
	◆商品コード：MMG23LY8434 ◆発行会社（リサーチ会社）：Market Monitor Global ◆発行日：2023年7月（※2025年版があります。お問い合わせください。） ◆ページ数：111 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後2-3営業日） ◆調査対象地域：グローバル ◆産業分野：医薬品＆ヘルスケア

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥468,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥608,400	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥702,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Corticosteroid Eyedrops Market 調査レポートは次の情報を含め、グローバルにおけるの副腎皮質ステロイド点眼薬市場規模と予測を収録しています。・世界の副腎皮質ステロイド点眼薬市場：売上、2018年-2023年、2024年-2029年
・世界の副腎皮質ステロイド点眼薬市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の副腎皮質ステロイド点眼薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「コルチゾン」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

副腎皮質ステロイド点眼薬のグローバル主要企業は、Novartis AG、 Allergan, Inc.、 Meda Pharmaceuticals Inc、 Bausch & Lomb Inc、 Cigna、 Similasan Corporation、 Visine、 Alcon、 Viva Opti-Free、 Bausch & Lomb、 Systane、 Rite Aid、 Walgreens、 Staples、 Clear eyesなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、副腎皮質ステロイド点眼薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の副腎皮質ステロイド点眼薬市場：タイプ別、2018年-2023年、2024年-2029年
世界の副腎皮質ステロイド点眼薬市場：タイプ別市場シェア、2022年
・コルチゾン、デキサメタゾン、トブラデックス、その他

世界の副腎皮質ステロイド点眼薬市場：用途別、2018年-2023年、2024年-2029年
世界の副腎皮質ステロイド点眼薬市場：用途別市場シェア、2022年
・大人、子供

世界の副腎皮質ステロイド点眼薬市場：地域・国別、2018年-2023年、2024年-2029年
世界の副腎皮質ステロイド点眼薬市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における副腎皮質ステロイド点眼薬のグローバル売上、2018年-2023年
・主要企業における副腎皮質ステロイド点眼薬のグローバル売上シェア、2022年
・主要企業における副腎皮質ステロイド点眼薬のグローバル販売量、2018年-2023年
・主要企業における副腎皮質ステロイド点眼薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Novartis AG、 Allergan, Inc.、 Meda Pharmaceuticals Inc、 Bausch & Lomb Inc、 Cigna、 Similasan Corporation、 Visine、 Alcon、 Viva Opti-Free、 Bausch & Lomb、 Systane、 Rite Aid、 Walgreens、 Staples、 Clear eyes

*************************************************************

・調査・分析レポートの概要
副腎皮質ステロイド点眼薬市場の定義
市場セグメント
世界の副腎皮質ステロイド点眼薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の副腎皮質ステロイド点眼薬市場規模
世界の副腎皮質ステロイド点眼薬市場規模：2022年 VS 2029年
世界の副腎皮質ステロイド点眼薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの副腎皮質ステロイド点眼薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の副腎皮質ステロイド点眼薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：コルチゾン、デキサメタゾン、トブラデックス、その他
副腎皮質ステロイド点眼薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：大人、子供
副腎皮質ステロイド点眼薬の用途別グローバル売上・予測

・地域別市場分析
地域別副腎皮質ステロイド点眼薬市場規模 2022年と2029年
地域別副腎皮質ステロイド点眼薬売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Novartis AG、 Allergan, Inc.、 Meda Pharmaceuticals Inc、 Bausch & Lomb Inc、 Cigna、 Similasan Corporation、 Visine、 Alcon、 Viva Opti-Free、 Bausch & Lomb、 Systane、 Rite Aid、 Walgreens、 Staples、 Clear eyes
...

Corticosteroid eye drops are used to treat severe, long-term eye allergy symptoms. Prescription steroid eye drops include loteprednol (Alrex, Lotemax).
This report aims to provide a comprehensive presentation of the global market for Corticosteroid Eyedrops, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Corticosteroid Eyedrops. This report contains market size and forecasts of Corticosteroid Eyedrops in global, including the following market information:
Global Corticosteroid Eyedrops Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Corticosteroid Eyedrops Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Corticosteroid Eyedrops companies in 2022 (%)
The global Corticosteroid Eyedrops market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Cortisone Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Corticosteroid Eyedrops include Novartis AG, Allergan, Inc., Meda Pharmaceuticals Inc, Bausch & Lomb Inc, Cigna, Similasan Corporation, Visine, Alcon and Viva Opti-Free, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Corticosteroid Eyedrops manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Corticosteroid Eyedrops Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Corticosteroid Eyedrops Market Segment Percentages, by Type, 2022 (%)
Cortisone
Dexamethasone
Tobradex
Others
Global Corticosteroid Eyedrops Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Corticosteroid Eyedrops Market Segment Percentages, by Application, 2022 (%)
Adult
Children
Global Corticosteroid Eyedrops Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Corticosteroid Eyedrops Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Corticosteroid Eyedrops revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Corticosteroid Eyedrops revenues share in global market, 2022 (%)
Key companies Corticosteroid Eyedrops sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Corticosteroid Eyedrops sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis AG
Allergan, Inc.
Meda Pharmaceuticals Inc
Bausch & Lomb Inc
Cigna
Similasan Corporation
Visine
Alcon
Viva Opti-Free
Bausch & Lomb
Systane
Rite Aid
Walgreens
Staples
Clear eyes
Outline of Major Chapters:
Chapter 1: Introduces the definition of Corticosteroid Eyedrops, market overview.
Chapter 2: Global Corticosteroid Eyedrops market size in revenue and volume.
Chapter 3: Detailed analysis of Corticosteroid Eyedrops manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Corticosteroid Eyedrops in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Corticosteroid Eyedrops capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Corticosteroid Eyedrops Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Corticosteroid Eyedrops Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Corticosteroid Eyedrops Overall Market Size
2.1 Global Corticosteroid Eyedrops Market Size: 2022 VS 2029
2.2 Global Corticosteroid Eyedrops Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Corticosteroid Eyedrops Sales: 2018-2029
3 Company Landscape
3.1 Top Corticosteroid Eyedrops Players in Global Market
3.2 Top Global Corticosteroid Eyedrops Companies Ranked by Revenue
3.3 Global Corticosteroid Eyedrops Revenue by Companies
3.4 Global Corticosteroid Eyedrops Sales by Companies
3.5 Global Corticosteroid Eyedrops Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Corticosteroid Eyedrops Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Corticosteroid Eyedrops Product Type
3.8 Tier 1, Tier 2 and Tier 3 Corticosteroid Eyedrops Players in Global Market
3.8.1 List of Global Tier 1 Corticosteroid Eyedrops Companies
3.8.2 List of Global Tier 2 and Tier 3 Corticosteroid Eyedrops Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Corticosteroid Eyedrops Market Size Markets, 2022 & 2029
4.1.2 Cortisone
4.1.3 Dexamethasone
4.1.4 Tobradex
4.1.5 Others
4.2 By Type – Global Corticosteroid Eyedrops Revenue & Forecasts
4.2.1 By Type – Global Corticosteroid Eyedrops Revenue, 2018-2023
4.2.2 By Type – Global Corticosteroid Eyedrops Revenue, 2024-2029
4.2.3 By Type – Global Corticosteroid Eyedrops Revenue Market Share, 2018-2029
4.3 By Type – Global Corticosteroid Eyedrops Sales & Forecasts
4.3.1 By Type – Global Corticosteroid Eyedrops Sales, 2018-2023
4.3.2 By Type – Global Corticosteroid Eyedrops Sales, 2024-2029
4.3.3 By Type – Global Corticosteroid Eyedrops Sales Market Share, 2018-2029
4.4 By Type – Global Corticosteroid Eyedrops Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Corticosteroid Eyedrops Market Size, 2022 & 2029
5.1.2 Adult
5.1.3 Children
5.2 By Application – Global Corticosteroid Eyedrops Revenue & Forecasts
5.2.1 By Application – Global Corticosteroid Eyedrops Revenue, 2018-2023
5.2.2 By Application – Global Corticosteroid Eyedrops Revenue, 2024-2029
5.2.3 By Application – Global Corticosteroid Eyedrops Revenue Market Share, 2018-2029
5.3 By Application – Global Corticosteroid Eyedrops Sales & Forecasts
5.3.1 By Application – Global Corticosteroid Eyedrops Sales, 2018-2023
5.3.2 By Application – Global Corticosteroid Eyedrops Sales, 2024-2029
5.3.3 By Application – Global Corticosteroid Eyedrops Sales Market Share, 2018-2029
5.4 By Application – Global Corticosteroid Eyedrops Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Corticosteroid Eyedrops Market Size, 2022 & 2029
6.2 By Region – Global Corticosteroid Eyedrops Revenue & Forecasts
6.2.1 By Region – Global Corticosteroid Eyedrops Revenue, 2018-2023
6.2.2 By Region – Global Corticosteroid Eyedrops Revenue, 2024-2029
6.2.3 By Region – Global Corticosteroid Eyedrops Revenue Market Share, 2018-2029
6.3 By Region – Global Corticosteroid Eyedrops Sales & Forecasts
6.3.1 By Region – Global Corticosteroid Eyedrops Sales, 2018-2023
6.3.2 By Region – Global Corticosteroid Eyedrops Sales, 2024-2029
6.3.3 By Region – Global Corticosteroid Eyedrops Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Corticosteroid Eyedrops Revenue, 2018-2029
6.4.2 By Country – North America Corticosteroid Eyedrops Sales, 2018-2029
6.4.3 US Corticosteroid Eyedrops Market Size, 2018-2029
6.4.4 Canada Corticosteroid Eyedrops Market Size, 2018-2029
6.4.5 Mexico Corticosteroid Eyedrops Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Corticosteroid Eyedrops Revenue, 2018-2029
6.5.2 By Country – Europe Corticosteroid Eyedrops Sales, 2018-2029
6.5.3 Germany Corticosteroid Eyedrops Market Size, 2018-2029
6.5.4 France Corticosteroid Eyedrops Market Size, 2018-2029
6.5.5 U.K. Corticosteroid Eyedrops Market Size, 2018-2029
6.5.6 Italy Corticosteroid Eyedrops Market Size, 2018-2029
6.5.7 Russia Corticosteroid Eyedrops Market Size, 2018-2029
6.5.8 Nordic Countries Corticosteroid Eyedrops Market Size, 2018-2029
6.5.9 Benelux Corticosteroid Eyedrops Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Corticosteroid Eyedrops Revenue, 2018-2029
6.6.2 By Region – Asia Corticosteroid Eyedrops Sales, 2018-2029
6.6.3 China Corticosteroid Eyedrops Market Size, 2018-2029
6.6.4 Japan Corticosteroid Eyedrops Market Size, 2018-2029
6.6.5 South Korea Corticosteroid Eyedrops Market Size, 2018-2029
6.6.6 Southeast Asia Corticosteroid Eyedrops Market Size, 2018-2029
6.6.7 India Corticosteroid Eyedrops Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Corticosteroid Eyedrops Revenue, 2018-2029
6.7.2 By Country – South America Corticosteroid Eyedrops Sales, 2018-2029
6.7.3 Brazil Corticosteroid Eyedrops Market Size, 2018-2029
6.7.4 Argentina Corticosteroid Eyedrops Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Corticosteroid Eyedrops Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Corticosteroid Eyedrops Sales, 2018-2029
6.8.3 Turkey Corticosteroid Eyedrops Market Size, 2018-2029
6.8.4 Israel Corticosteroid Eyedrops Market Size, 2018-2029
6.8.5 Saudi Arabia Corticosteroid Eyedrops Market Size, 2018-2029
6.8.6 UAE Corticosteroid Eyedrops Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Novartis AG
7.1.1 Novartis AG Company Summary
7.1.2 Novartis AG Business Overview
7.1.3 Novartis AG Corticosteroid Eyedrops Major Product Offerings
7.1.4 Novartis AG Corticosteroid Eyedrops Sales and Revenue in Global (2018-2023)
7.1.5 Novartis AG Key News & Latest Developments
7.2 Allergan, Inc.
7.2.1 Allergan, Inc. Company Summary
7.2.2 Allergan, Inc. Business Overview
7.2.3 Allergan, Inc. Corticosteroid Eyedrops Major Product Offerings
7.2.4 Allergan, Inc. Corticosteroid Eyedrops Sales and Revenue in Global (2018-2023)
7.2.5 Allergan, Inc. Key News & Latest Developments
7.3 Meda Pharmaceuticals Inc
7.3.1 Meda Pharmaceuticals Inc Company Summary
7.3.2 Meda Pharmaceuticals Inc Business Overview
7.3.3 Meda Pharmaceuticals Inc Corticosteroid Eyedrops Major Product Offerings
7.3.4 Meda Pharmaceuticals Inc Corticosteroid Eyedrops Sales and Revenue in Global (2018-2023)
7.3.5 Meda Pharmaceuticals Inc Key News & Latest Developments
7.4 Bausch & Lomb Inc
7.4.1 Bausch & Lomb Inc Company Summary
7.4.2 Bausch & Lomb Inc Business Overview
7.4.3 Bausch & Lomb Inc Corticosteroid Eyedrops Major Product Offerings
7.4.4 Bausch & Lomb Inc Corticosteroid Eyedrops Sales and Revenue in Global (2018-2023)
7.4.5 Bausch & Lomb Inc Key News & Latest Developments
7.5 Cigna
7.5.1 Cigna Company Summary
7.5.2 Cigna Business Overview
7.5.3 Cigna Corticosteroid Eyedrops Major Product Offerings
7.5.4 Cigna Corticosteroid Eyedrops Sales and Revenue in Global (2018-2023)
7.5.5 Cigna Key News & Latest Developments
7.6 Similasan Corporation
7.6.1 Similasan Corporation Company Summary
7.6.2 Similasan Corporation Business Overview
7.6.3 Similasan Corporation Corticosteroid Eyedrops Major Product Offerings
7.6.4 Similasan Corporation Corticosteroid Eyedrops Sales and Revenue in Global (2018-2023)
7.6.5 Similasan Corporation Key News & Latest Developments
7.7 Visine
7.7.1 Visine Company Summary
7.7.2 Visine Business Overview
7.7.3 Visine Corticosteroid Eyedrops Major Product Offerings
7.7.4 Visine Corticosteroid Eyedrops Sales and Revenue in Global (2018-2023)
7.7.5 Visine Key News & Latest Developments
7.8 Alcon
7.8.1 Alcon Company Summary
7.8.2 Alcon Business Overview
7.8.3 Alcon Corticosteroid Eyedrops Major Product Offerings
7.8.4 Alcon Corticosteroid Eyedrops Sales and Revenue in Global (2018-2023)
7.8.5 Alcon Key News & Latest Developments
7.9 Viva Opti-Free
7.9.1 Viva Opti-Free Company Summary
7.9.2 Viva Opti-Free Business Overview
7.9.3 Viva Opti-Free Corticosteroid Eyedrops Major Product Offerings
7.9.4 Viva Opti-Free Corticosteroid Eyedrops Sales and Revenue in Global (2018-2023)
7.9.5 Viva Opti-Free Key News & Latest Developments
7.10 Bausch & Lomb
7.10.1 Bausch & Lomb Company Summary
7.10.2 Bausch & Lomb Business Overview
7.10.3 Bausch & Lomb Corticosteroid Eyedrops Major Product Offerings
7.10.4 Bausch & Lomb Corticosteroid Eyedrops Sales and Revenue in Global (2018-2023)
7.10.5 Bausch & Lomb Key News & Latest Developments
7.11 Systane
7.11.1 Systane Company Summary
7.11.2 Systane Corticosteroid Eyedrops Business Overview
7.11.3 Systane Corticosteroid Eyedrops Major Product Offerings
7.11.4 Systane Corticosteroid Eyedrops Sales and Revenue in Global (2018-2023)
7.11.5 Systane Key News & Latest Developments
7.12 Rite Aid
7.12.1 Rite Aid Company Summary
7.12.2 Rite Aid Corticosteroid Eyedrops Business Overview
7.12.3 Rite Aid Corticosteroid Eyedrops Major Product Offerings
7.12.4 Rite Aid Corticosteroid Eyedrops Sales and Revenue in Global (2018-2023)
7.12.5 Rite Aid Key News & Latest Developments
7.13 Walgreens
7.13.1 Walgreens Company Summary
7.13.2 Walgreens Corticosteroid Eyedrops Business Overview
7.13.3 Walgreens Corticosteroid Eyedrops Major Product Offerings
7.13.4 Walgreens Corticosteroid Eyedrops Sales and Revenue in Global (2018-2023)
7.13.5 Walgreens Key News & Latest Developments
7.14 Staples
7.14.1 Staples Company Summary
7.14.2 Staples Business Overview
7.14.3 Staples Corticosteroid Eyedrops Major Product Offerings
7.14.4 Staples Corticosteroid Eyedrops Sales and Revenue in Global (2018-2023)
7.14.5 Staples Key News & Latest Developments
7.15 Clear eyes
7.15.1 Clear eyes Company Summary
7.15.2 Clear eyes Business Overview
7.15.3 Clear eyes Corticosteroid Eyedrops Major Product Offerings
7.15.4 Clear eyes Corticosteroid Eyedrops Sales and Revenue in Global (2018-2023)
7.15.5 Clear eyes Key News & Latest Developments
8 Global Corticosteroid Eyedrops Production Capacity, Analysis
8.1 Global Corticosteroid Eyedrops Production Capacity, 2018-2029
8.2 Corticosteroid Eyedrops Production Capacity of Key Manufacturers in Global Market
8.3 Global Corticosteroid Eyedrops Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Corticosteroid Eyedrops Supply Chain Analysis
10.1 Corticosteroid Eyedrops Industry Value Chain
10.2 Corticosteroid Eyedrops Upstream Market
10.3 Corticosteroid Eyedrops Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Corticosteroid Eyedrops Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Corticosteroid Eyedrops in Global Market
Table 2. Top Corticosteroid Eyedrops Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Corticosteroid Eyedrops Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Corticosteroid Eyedrops Revenue Share by Companies, 2018-2023
Table 5. Global Corticosteroid Eyedrops Sales by Companies, (K Units), 2018-2023
Table 6. Global Corticosteroid Eyedrops Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Corticosteroid Eyedrops Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Corticosteroid Eyedrops Product Type
Table 9. List of Global Tier 1 Corticosteroid Eyedrops Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Corticosteroid Eyedrops Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Corticosteroid Eyedrops Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Corticosteroid Eyedrops Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Corticosteroid Eyedrops Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Corticosteroid Eyedrops Sales (K Units), 2018-2023
Table 15. By Type - Global Corticosteroid Eyedrops Sales (K Units), 2024-2029
Table 16. By Application – Global Corticosteroid Eyedrops Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Corticosteroid Eyedrops Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Corticosteroid Eyedrops Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Corticosteroid Eyedrops Sales (K Units), 2018-2023
Table 20. By Application - Global Corticosteroid Eyedrops Sales (K Units), 2024-2029
Table 21. By Region – Global Corticosteroid Eyedrops Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Corticosteroid Eyedrops Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Corticosteroid Eyedrops Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Corticosteroid Eyedrops Sales (K Units), 2018-2023
Table 25. By Region - Global Corticosteroid Eyedrops Sales (K Units), 2024-2029
Table 26. By Country - North America Corticosteroid Eyedrops Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Corticosteroid Eyedrops Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Corticosteroid Eyedrops Sales, (K Units), 2018-2023
Table 29. By Country - North America Corticosteroid Eyedrops Sales, (K Units), 2024-2029
Table 30. By Country - Europe Corticosteroid Eyedrops Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Corticosteroid Eyedrops Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Corticosteroid Eyedrops Sales, (K Units), 2018-2023
Table 33. By Country - Europe Corticosteroid Eyedrops Sales, (K Units), 2024-2029
Table 34. By Region - Asia Corticosteroid Eyedrops Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Corticosteroid Eyedrops Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Corticosteroid Eyedrops Sales, (K Units), 2018-2023
Table 37. By Region - Asia Corticosteroid Eyedrops Sales, (K Units), 2024-2029
Table 38. By Country - South America Corticosteroid Eyedrops Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Corticosteroid Eyedrops Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Corticosteroid Eyedrops Sales, (K Units), 2018-2023
Table 41. By Country - South America Corticosteroid Eyedrops Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Corticosteroid Eyedrops Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Corticosteroid Eyedrops Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Corticosteroid Eyedrops Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Corticosteroid Eyedrops Sales, (K Units), 2024-2029
Table 46. Novartis AG Company Summary
Table 47. Novartis AG Corticosteroid Eyedrops Product Offerings
Table 48. Novartis AG Corticosteroid Eyedrops Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Novartis AG Key News & Latest Developments
Table 50. Allergan, Inc. Company Summary
Table 51. Allergan, Inc. Corticosteroid Eyedrops Product Offerings
Table 52. Allergan, Inc. Corticosteroid Eyedrops Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Allergan, Inc. Key News & Latest Developments
Table 54. Meda Pharmaceuticals Inc Company Summary
Table 55. Meda Pharmaceuticals Inc Corticosteroid Eyedrops Product Offerings
Table 56. Meda Pharmaceuticals Inc Corticosteroid Eyedrops Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. Meda Pharmaceuticals Inc Key News & Latest Developments
Table 58. Bausch & Lomb Inc Company Summary
Table 59. Bausch & Lomb Inc Corticosteroid Eyedrops Product Offerings
Table 60. Bausch & Lomb Inc Corticosteroid Eyedrops Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. Bausch & Lomb Inc Key News & Latest Developments
Table 62. Cigna Company Summary
Table 63. Cigna Corticosteroid Eyedrops Product Offerings
Table 64. Cigna Corticosteroid Eyedrops Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. Cigna Key News & Latest Developments
Table 66. Similasan Corporation Company Summary
Table 67. Similasan Corporation Corticosteroid Eyedrops Product Offerings
Table 68. Similasan Corporation Corticosteroid Eyedrops Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. Similasan Corporation Key News & Latest Developments
Table 70. Visine Company Summary
Table 71. Visine Corticosteroid Eyedrops Product Offerings
Table 72. Visine Corticosteroid Eyedrops Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 73. Visine Key News & Latest Developments
Table 74. Alcon Company Summary
Table 75. Alcon Corticosteroid Eyedrops Product Offerings
Table 76. Alcon Corticosteroid Eyedrops Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 77. Alcon Key News & Latest Developments
Table 78. Viva Opti-Free Company Summary
Table 79. Viva Opti-Free Corticosteroid Eyedrops Product Offerings
Table 80. Viva Opti-Free Corticosteroid Eyedrops Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 81. Viva Opti-Free Key News & Latest Developments
Table 82. Bausch & Lomb Company Summary
Table 83. Bausch & Lomb Corticosteroid Eyedrops Product Offerings
Table 84. Bausch & Lomb Corticosteroid Eyedrops Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 85. Bausch & Lomb Key News & Latest Developments
Table 86. Systane Company Summary
Table 87. Systane Corticosteroid Eyedrops Product Offerings
Table 88. Systane Corticosteroid Eyedrops Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 89. Systane Key News & Latest Developments
Table 90. Rite Aid Company Summary
Table 91. Rite Aid Corticosteroid Eyedrops Product Offerings
Table 92. Rite Aid Corticosteroid Eyedrops Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 93. Rite Aid Key News & Latest Developments
Table 94. Walgreens Company Summary
Table 95. Walgreens Corticosteroid Eyedrops Product Offerings
Table 96. Walgreens Corticosteroid Eyedrops Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 97. Walgreens Key News & Latest Developments
Table 98. Staples Company Summary
Table 99. Staples Corticosteroid Eyedrops Product Offerings
Table 100. Staples Corticosteroid Eyedrops Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 101. Staples Key News & Latest Developments
Table 102. Clear eyes Company Summary
Table 103. Clear eyes Corticosteroid Eyedrops Product Offerings
Table 104. Clear eyes Corticosteroid Eyedrops Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 105. Clear eyes Key News & Latest Developments
Table 106. Corticosteroid Eyedrops Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 107. Global Corticosteroid Eyedrops Capacity Market Share of Key Manufacturers, 2021-2023
Table 108. Global Corticosteroid Eyedrops Production by Region, 2018-2023 (K Units)
Table 109. Global Corticosteroid Eyedrops Production by Region, 2024-2029 (K Units)
Table 110. Corticosteroid Eyedrops Market Opportunities & Trends in Global Market
Table 111. Corticosteroid Eyedrops Market Drivers in Global Market
Table 112. Corticosteroid Eyedrops Market Restraints in Global Market
Table 113. Corticosteroid Eyedrops Raw Materials
Table 114. Corticosteroid Eyedrops Raw Materials Suppliers in Global Market
Table 115. Typical Corticosteroid Eyedrops Downstream
Table 116. Corticosteroid Eyedrops Downstream Clients in Global Market
Table 117. Corticosteroid Eyedrops Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Corticosteroid Eyedrops Segment by Type in 2022
Figure 2. Corticosteroid Eyedrops Segment by Application in 2022
Figure 3. Global Corticosteroid Eyedrops Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Corticosteroid Eyedrops Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Corticosteroid Eyedrops Revenue, 2018-2029 (US$, Mn)
Figure 7. Corticosteroid Eyedrops Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Corticosteroid Eyedrops Revenue in 2022
Figure 9. By Type - Global Corticosteroid Eyedrops Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Corticosteroid Eyedrops Revenue Market Share, 2018-2029
Figure 11. By Type - Global Corticosteroid Eyedrops Sales Market Share, 2018-2029
Figure 12. By Type - Global Corticosteroid Eyedrops Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Corticosteroid Eyedrops Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Corticosteroid Eyedrops Revenue Market Share, 2018-2029
Figure 15. By Application - Global Corticosteroid Eyedrops Sales Market Share, 2018-2029
Figure 16. By Application - Global Corticosteroid Eyedrops Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Corticosteroid Eyedrops Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Corticosteroid Eyedrops Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Corticosteroid Eyedrops Revenue Market Share, 2018-2029
Figure 20. By Region - Global Corticosteroid Eyedrops Sales Market Share, 2018-2029
Figure 21. By Country - North America Corticosteroid Eyedrops Revenue Market Share, 2018-2029
Figure 22. By Country - North America Corticosteroid Eyedrops Sales Market Share, 2018-2029
Figure 23. US Corticosteroid Eyedrops Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Corticosteroid Eyedrops Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Corticosteroid Eyedrops Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Corticosteroid Eyedrops Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Corticosteroid Eyedrops Sales Market Share, 2018-2029
Figure 28. Germany Corticosteroid Eyedrops Revenue, (US$, Mn), 2018-2029
Figure 29. France Corticosteroid Eyedrops Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Corticosteroid Eyedrops Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Corticosteroid Eyedrops Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Corticosteroid Eyedrops Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Corticosteroid Eyedrops Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Corticosteroid Eyedrops Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Corticosteroid Eyedrops Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Corticosteroid Eyedrops Sales Market Share, 2018-2029
Figure 37. China Corticosteroid Eyedrops Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Corticosteroid Eyedrops Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Corticosteroid Eyedrops Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Corticosteroid Eyedrops Revenue, (US$, Mn), 2018-2029
Figure 41. India Corticosteroid Eyedrops Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Corticosteroid Eyedrops Revenue Market Share, 2018-2029
Figure 43. By Country - South America Corticosteroid Eyedrops Sales Market Share, 2018-2029
Figure 44. Brazil Corticosteroid Eyedrops Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Corticosteroid Eyedrops Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Corticosteroid Eyedrops Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Corticosteroid Eyedrops Sales Market Share, 2018-2029
Figure 48. Turkey Corticosteroid Eyedrops Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Corticosteroid Eyedrops Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Corticosteroid Eyedrops Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Corticosteroid Eyedrops Revenue, (US$, Mn), 2018-2029
Figure 52. Global Corticosteroid Eyedrops Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Corticosteroid Eyedrops by Region, 2022 VS 2029
Figure 54. Corticosteroid Eyedrops Industry Value Chain
Figure 55. Marketing Channels

※参考情報

副腎皮質ステロイド点眼薬は、眼科で広く使用される薬剤であり、主に炎症を抑制するために利用されます。これらの薬剤は、副腎皮質から分泌されるホルモンに類似した合成物質であり、強力な抗炎症作用を持ち、さまざまな眼疾患の治療に役立っています。

この薬剤の特徴としてはまず、抗炎症効果が挙げられます。副腎皮質ステロイドは、細胞中の炎症メディエーターの合成や放出を抑制する働きがあるため、眼の炎症を緩和することができます。また、これらの薬剤は、免疫反応を抑制する効果もあり、アレルギー性結膜炎や角膜炎などの病態にも効果的です。

副腎皮質ステロイド点眼薬にはいくつかの種類がありますが、主なものとしては、ヒドロコルチゾン、デキサメタゾン、ベタメタゾン、トリアムシノロンなどが挙げられます。これらはそれぞれ異なる強さや効能を持ち、疾患の種類や患者の状態に応じて使い分けられます。例えば、デキサメタゾンは比較的強力な作用を持ち、炎症が強い場合に使用されることが一般的です。一方、ヒドロコルチゾンは比較的弱いステロイドであり、軽度の炎症には適しています。

用途に関しては、副腎皮質ステロイド点眼薬は、慢性炎症性疾患、アレルギー反応、外傷後の炎症、術後の管理など、さまざまな場面で使用されます。具体的には、アレルギー性結膜炎、角膜炎、ぶどう膜炎（眼内炎症の一種）、ドライアイ症候群に関連する炎症、さらには手術後の炎症予防などが挙げられます。また、これらの薬剤は眼科だけでなく、耳鼻咽喉科や皮膚科などの領域でも使用されることがあります。

副腎皮質ステロイド点眼薬を使用する際には、注意が必要です。長期使用や高用量での使用は、眼圧上昇や白内障の形成といった副作用を引き起こす可能性があるため、治療期間や用量を慎重に管理することが求められます。また、急に使用を中止することも避けるべきであり、徐々に減量することが推奨される場合が多いです。

最近では、これらの薬剤の効果を最大限に引き出すために、さまざまな関連技術も発展しています。例えば、ナノテクノロジーを活用した薬剤の微小化により、点眼時における薬剤の吸収率が高まる研究が進められています。また、持続性を向上させるための徐放性製剤や、局所用の薬物送達システムが開発されることで、患者の負担を軽減し、治療効果を高める取り組みも行われています。

統計的に見ても、眼科領域での副腎皮質ステロイド点眼薬の使用頻度は非常に高く、その効果の高さから多くの眼疾患に対して標準的な治療法とされています。医師や患者がこれらの薬剤を上手に利用することで、炎症のコントロールや症状の緩和が実現でき、日常生活の質の向上へとつながります。

要約すると、副腎皮質ステロイド点眼薬は強力な抗炎症作用を持つ眼科治療薬であり、さまざまな眼疾患に対して使用されます。種類は複数あり、それぞれの特性に応じて使い分けることが求められます。副作用に対する注意も必要であり、医師の指導のもとで適切に使用することが重要です。また、関連技術の進展により、より効果的で安全な治療法への期待も高まっています。眼の健康を維持するために、こうした薬剤や技術の理解と活用が大切です。

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 副腎皮質ステロイド点眼薬の世界市場見通し2023年-2029年(Corticosteroid Eyedrops Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

副腎皮質ステロイド点眼薬の世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp